University of Tasmania
Browse

File(s) under permanent embargo

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

journal contribution
posted on 2023-05-21, 11:59 authored by Keighley, C, Louise CooleyLouise Cooley, Morris, AJ, Ritchie, D, Clark, JE, Boan, P, Worth, LJ
Patients with haematological malignancies, haemopoietic stem cell transplant recipients and patients requiring admission to intensive care settings are at high risk for invasive candidiasis (IC). Over the past decade, there has been increased reporting of non-albicans species and fluconazole resistance in Australia. These guidelines provide updated evidence-based recommendations for the diagnosis and management of IC in adult and paediatric haematology, oncology and intensive care settings. Optimal pharmacological and non-pharmacological management are discussed. Recent studies strengthen the recommendation for an echinocandin agent as first-line therapy for high-risk patients with IC. Mortality benefit has also been demonstrated for non-pharmacological management, including removal of central venous catheters, infectious diseases consultation and use of care bundles. Healthcare facilities managing immunocompromised patient populations should therefore adopt implementation strategies for these multimodal interventions.

History

Publication title

Internal Medicine Journal

Volume

51

Issue

S7

Pagination

89-117

ISSN

1444-0903

Department/School

Tasmanian School of Medicine

Publisher

John Wiley & Sons, Inc

Place of publication

Australia

Rights statement

© 2021 Royal Australasian College of Physicians.

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified; Expanding knowledge in the health sciences

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC